JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A8735 XMU-MP-1
2 Citation

Target: MST

Summary: MST1/2 inhibitor, potent and selective

≥41.6 mg/mL
A3011 CHIR-99021 (CT99021)
2 Citation

Target: GSK-3

Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive

≥23.27 mg/mL
A3021 GDC-0449 (Vismodegib)
1 Citation

Target: P-glycoprotein (P-gp)|Hedgehog

Summary: Hedgehog antagonist,potent and selective

≥21.08 mg/mL
A1905 3-Deazaneplanocin,DZNep
6 Citation

Target: Hydrolase

Summary: S-adenosylhomocysteine and EZH2 inhibitor

insoluble in EtOH; ≥17.07 mg/mL
A4351 PluriSIn #1 (NSC 14613)

Target: Stearoyl-CoA 9-desaturase (SCD-1)

Summary: SCD1 inhibitor
A3184 AR-A014418
2 Citation

Target: GSK-3

Summary: GSK3β inhibitor, ATP-competitive and selective

insoluble in EtOH; insoluble in H2O; ≥15.4 mg/mL
A3258 BMS-833923

Target: Smoothened

Summary: Smoothened inhibitor

≥47.4 mg/mL
A3413 FH535

Summary: Wnt/B-catenin inhibitor

≥36.1 mg/mL
A3446 GSK126
5 Citation

Target: EZH2

Summary: EZH2 inhibitor

insoluble in H2O; insoluble in EtOH; ≥4.38 mg/mL
A3543 LDE225 Diphosphate

Target: Smoothened

Summary: Smo antagonist

≥27.85 mg/mL